Century Therapeutics, Inc. – Initiation of Phase 1 CALiPSO-1 Trial of CNTY-101 in Systemic Lupus Erythematosus, marking strategic expansion into autoimmune disease; protocol amended to include...
WYOMISSING, Pa., August 08, 2024–(BUSINESS WIRE)–PENN Entertainment, Inc. (“PENN” or the “Company”) (Nasdaq: PENN) today reported financial results for the three and six months ended June...
ALBANY, N.Y., August 07, 2024–(BUSINESS WIRE)–Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH), a developer of green data centers for intensive computing applications including Bitcoin...
AMSC Q1 Financial Highlights: Revenue Increased Over 33% Year Over Year to $40 Million Reported Expanded Gross Margin and Achieved Non-GAAP Net Income Generated $3.4 Million of Operating Cash Flow Company...
GeoVax, Inc. Awarded BARDA Project NextGen (PNG) contract to advance GeoVax’s multi-antigen vaccine candidate, GEO-CM04S1, into 10,000-participant randomized, comparative Phase 2b COVID-19 vaccine study BARDA PNG...
CANTON, Ohio, Aug. 5, 2024 /PRNewswire/ — Hall of Fame Resort & Entertainment Company (NASDAQ: HOFV, HOFVW), the only resort, entertainment, and media company centered around...
Axsome Therapeutics, Inc. Total 2Q 2024 net product revenue of $87.2 million, representing 87% year-over-year growth Auvelity® 2Q 2024 net product sales of $65.0 million, representing...
Chip giant Intel (INTC) reported its second quarter earnings after the bell on Thursday, missing on the top and bottom lines and announcing a $10 billion...
– Provides Scaled Aggregates-Led Platform with Revenues of $283 Million, Adjusted EBITDA of $100 Million, and Margin Accretive to Construction Products Segment – Extends Footprint into...
BridgeBio Pharma, Inc. Acoramidis demonstrated a significant impact on mortality, hospitalizations, and quality of life Starting at Month 3, patients taking acoramidis showed meaningful and sustained improvement in time...